Compare SILO & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SILO | SGD |
|---|---|---|
| Founded | 2010 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0M | 7.4M |
| IPO Year | N/A | N/A |
| Metric | SILO | SGD |
|---|---|---|
| Price | $0.41 | $0.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 132.6K | ★ 2.0M |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $72,102.00 | ★ $4,970,752.00 |
| Revenue This Year | $1.86 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2770.15 |
| 52 Week Low | $0.36 | $0.20 |
| 52 Week High | $3.37 | $3.03 |
| Indicator | SILO | SGD |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 21.56 |
| Support Level | $0.42 | $0.20 |
| Resistance Level | $0.46 | $0.30 |
| Average True Range (ATR) | 0.02 | 0.11 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 2.22 | 2.84 |
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.